Vancouver, BC & NY – Integrated Nanotherapeutics (INT), a biotechnology company developing innovative treatments for autoimmune diseases, has received an award from Breakthrough T1D (formerly JDRF) to advance INT’s technology… Read More
B.C.’s health care organizations are driving evidence-based practice improvements and elevating patient care across the province. The Knowledge Translation (KT) Challenge is an annual program that has been run in collaboration with… Read More
New longer-term data from the MARIPOSA study confirm superior outcomes of chemotherapy-free RYBREVANT® plus LAZCLUZE™ regimen compared to osimertinib monotherapy as first-line therapy Results from an interim analysis featured in… Read More
OTTAWA, ON – BioTalent Canada announced a new project, with extended funding from the Future Skills Centre, to develop cleanroom skills certification for Canadian bio-manufacturing. This will ensure that employers… Read More
Approved indications include the treatment of adult patients with von Hippel-Lindau (VHL) disease for associated non-metastatic renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastomas, or non-metastatic pancreatic neuroendocrine tumours… Read More
